Uchida Yoko Co Ltd
TSE:8057
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Realty Income Corp
NYSE:O
|
Real Estate
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Uchida Yoko Co Ltd
Cash & Cash Equivalents
Uchida Yoko Co Ltd
Cash & Cash Equivalents Peer Comparison
Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors
Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Uchida Yoko Co Ltd
TSE:8057
|
Cash & Cash Equivalents
ÂĄ28.3B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
8%
|
CAGR 10-Years
5%
|
|
Nomura Research Institute Ltd
TSE:4307
|
Cash & Cash Equivalents
ÂĄ173.9B
|
CAGR 3-Years
4%
|
CAGR 5-Years
7%
|
CAGR 10-Years
33%
|
|
Fujitsu Ltd
TSE:6702
|
Cash & Cash Equivalents
ÂĄ342.1B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
1%
|
|
NTT Data Corp
TSE:9613
|
Cash & Cash Equivalents
ÂĄ431.8B
|
CAGR 3-Years
15%
|
CAGR 5-Years
11%
|
CAGR 10-Years
9%
|
|
Obic Co Ltd
TSE:4684
|
Cash & Cash Equivalents
ÂĄ170.2B
|
CAGR 3-Years
4%
|
CAGR 5-Years
7%
|
CAGR 10-Years
12%
|
|
NEC Corp
TSE:6701
|
Cash & Cash Equivalents
ÂĄ476.5B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
11%
|
CAGR 10-Years
9%
|
See Also
What is Uchida Yoko Co Ltd's Cash & Cash Equivalents?
Cash & Cash Equivalents
28.3B
JPY
Based on the financial report for Apr 20, 2024, Uchida Yoko Co Ltd's Cash & Cash Equivalents amounts to 28.3B JPY.
What is Uchida Yoko Co Ltd's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
5%
Over the last year, the Cash & Cash Equivalents growth was -5%. The average annual Cash & Cash Equivalents growth rates for Uchida Yoko Co Ltd have been -6% over the past three years , 8% over the past five years , and 5% over the past ten years .